A panoramic view of RNA modifications: exploring new frontiers. by Zhang, Zijun et al.
UCLA
UCLA Previously Published Works
Title
A panoramic view of RNA modifications: exploring new frontiers.
Permalink
https://escholarship.org/uc/item/7sn779d8
Journal
Genome biology, 19(1)
ISSN
1474-7596
Authors
Zhang, Zijun
Park, Eddie
Lin, Lan
et al.
Publication Date
2018-01-30
DOI
10.1186/s13059-018-1394-4
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Zhang et al. Genome Biology  (2018) 19:11 
DOI 10.1186/s13059-018-1394-4MEETING REPORT Open AccessA panoramic view of RNA modifications:
exploring new frontiers
Zijun Zhang1, Eddie Park2, Lan Lin2 and Yi Xing1,2*Abstract
Meeting report on the Cold Spring Harbor Asia
conference on RNA Modifications and Epitranscriptomics,
held in Suzhou, China, 13–17 November, 2017.developed hMeRIP-seq for transcriptome-wide mappingIntroduction
Methods for transcriptome-wide analyses of RNA modi-
fications—highlighted as the 'Method of the Year 2016'
by Nature Methods—have recently revealed highly dy-
namic 'epitranscriptomes', in which RNA modifications
regulate gene activities and cellular phenotypes in health
and disease. The Cold Spring Harbor Asia (CSHA) con-
ference on RNA Modifications and Epitranscriptomics
highlighted cutting-edge research in this rapidly evolving
field. The conference was organized by Michaela Frye
(University of Cambridge, UK), Chuan He (University
of Chicago, USA), Tsutomu Suzuki (University of
Tokyo, Japan), and Yungui Yang (Beijing Institute of
Genomics, China), and included more than 50 talks
and hundreds of attendees.
Diverse types of RNA modifications
More than 140 types of chemical modifications have
been found in RNA. N6-methyladenosine (m6A) is the
most prevalent type of reversible internal modification
in eukaryotic mRNAs. Chuan He (University of Chicago)
characterized m6A-modified transcripts as entering a
separate track of fast decay and fast translation mediated
through m6A reader proteins. One reader protein,
YTHDF2, promotes m6A-mediated mRNA decay, while
another reader protein, YTHDF1, promotes mRNA
translation. The He group also discovered FTO and
ALKBH5 as erasers of m6A modification, and found that
these proteins have important functions. Misregulation* Correspondence: yxing@ucla.edu
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tiation and human diseases, in particular cancer.
Another RNA modification, 5-hydroxymethylcytosine
(5hmC), was characterized by Francois Fuks (Free
University of Brussels (ULB), Brussels). The Fuks group
of 5hmC. Their studies of 5hmC characteristics in mam-
malian embryonic stem cells (ESCs) revealed its enrich-
ment at the mRNA transcription start sites.
RNA tailing is another prevalent type of RNA modifi-
cations. To study the regulation of RNA tailing, Narry
Kim (Seoul National University, South Korea) and
colleagues developed TAIL-seq, which determines
transcriptome-wide poly-A tail length and 3’ end modifi-
cations simultaneously. Using TAIL-seq, they identified
CNOT as the major deadenylase and elucidated the
mechanistic interactions between the two CNOT sub-
units, CNOT6/6L and CNOT7/8, and the poly-A bind-
ing protein PABPC1. After PABPC1 and CNOT remove
poly-A tails, the uridylation-catalyzing enzymes TUT4
and TUT7 add a U-tail to deadenylated mRNAs. More
recently, the Kim group discovered that guanylation is
catalyzed by a subset of TUTs and slows down deadeny-
lation. The interplays of deadenylation, uridylation, and
guanylation reflect a complex regulatory network of
RNA modifications at the mRNA 3’ ends.
RNA editing is an abundant RNA modification.
Jian Lu (Peking University, China) discovered that
adenosine-to-inosine (A-to-I) RNA editing has provided
an adaptive evolutionary force through systematic analyses
of RNA editing sites in Drosophila brains. Eddie Park
(UCLA, USA) reported widespread population and allelic
variation of A-to-I RNA editing in human cells and pro-
posed a mechanism that is based on RNA secondary
structure.
New types of RNA modifications are being discovered.
Mark Helm (Johannes Gutenberg-University, Germany)
reported an LC-MS-based method to identify novel
RNA modifications. A proof-of-concept study detected
KDka427, a new RNA modification with a thioacetalle is distributed under the terms of the Creative Commons Attribution 4.0
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tribute to an expanding epitranscriptome vocabulary.Functional impacts of RNA modifications
Elucidating the functional significance of RNA modifica-
tions has been a major goal for the field. Numerous talks
focused on the impacts of RNA modifications in various
biological processes and diseases.
In virology, m6A regulates viral infection, as shown
by Stacy Horner (Duke University, USA) in Flaviviri-
dae, a family of RNA viruses. Specifically, m6A marks
the positive-sense-stranded RNA genomes of viruses
in this family and regulates the viral replicative life
cycle. The presence of m6A on viral functional ele-
ments suggests an additional layer of gene regulation
in virus-host interactions.
The immune response is also regulated by RNA modi-
fications. Brenda Bass (University of Utah, USA) pre-
sented findings on the roles of A-to-I RNA editing by
ADARs (adenosine deaminases that act on RNA) and
dsRNA termini-dependent cleavage by Dicer in immune
response. ADARs mark cellular dsRNAs to preclude the
antiviral response mediated by Dicer in invertebrates.
Bass and colleagues elucidated the mechanisms of differ-
ential ATP requirement by invertebrate Dicer and its re-
lationship with the recognition of self versus non-self
dsRNAs. Xuetao Cao (Chinese Academy of Medical
Sciences, China) discovered that in antiviral immune
responses, DDX46 inhibits immune response by retain-
ing m6A-modified antiviral transcripts in the nucleus.
On the other hand, TET2 represses the expression of
SOCS3, an inhibitor of the JAK3 pathway, by binding
and oxidizing m5C in the SOCS3 3’-UTR, thus promoting
infection-induced myelopoiesis. Jianlong Wang (Icahn
School of Medicine at Mount Sinai, USA) also described
critical roles of TET2 and RNA m5C oxidation in the
post-transcriptional regulation of endogenous retrovirus
(ERV) and ERV-associated genes in pluripotent stem cells.
Taurine modification of uridine in mitochondrial
transfer RNA plays a critical role in decoding during
protein synthesis. Tsutomu Suzuki (University of
Tokyo, Japan) and colleagues found that the lack of this
modification is a primary cause of mitochondrial dis-
eases, and proposed 'RNA modopathy' as a new class of
human diseases. Kazuhito Tomizawa (Kumamoto Uni-
versity, Japan) demonstrated the essential role of tau-
rine modification and its catalyzing enzyme Mto1 in
mitochondrial translation and in control of the proteos-
tasis network, which has therapeutic implications for
mitochondrial diseases.
RNA modifications have emerged as an important
regulatory axis of tumorigenesis. In subtypes of acute
myeloid leukemia (AML), Jianjun Chen (University ofCincinnati, USA) discovered that the m6A eraser FTO
acts as an oncogene in certain AML cells, and that inhi-
biting FTO activity can suppress leukemogenesis.
Furthermore, an oncometabolite, R-2-hydroxyglutarate
(R-2HG), exerts a broad anti-tumor activity by inhibiting
the FTO/m6A/MYC/CEBPA signaling axis in FTO-high
AML cells.
RNA modifications play a critical role in cell fate de-
termination. Michaela Frye (University of Cambridge,
UK) demonstrated that several mechanisms of RNA
modifications, in particular non-coding RNA modifica-
tions, regulate stem cell functions by providing a
molecular rheostat for protein synthesis in fast response
to environmental stimuli. For example, tRNA methyla-
tion responds to oxidative stress and regulates protein
synthesis in stem cells.
The mRNA cap is a collection of structures on the 5’
end of mRNA that recruit proteins mediating RNA pro-
cessing, export, and translation. Victoria Cowling
(University of Dundee, UK) described the identification
of the mRNA cap methyltransferase RAM and its regu-
latory role in ESC differentiation, and reported how its
methyltransferase-independent characteristics had been
revealed by cross-linking and immunoprecipitation se-
quencing (CLIP-seq) and chromatin immunoprecipita-
tion sequencing (ChIP-seq) experiments.
Several studies highlighted the functional roles of RNA
modifications in germline cells. Qi Chen (University of
Nevada, USA) illustrated the intergenerational transmis-
sion of paternally acquired traits via sperm. In particular,
he described paternally acquired metabolic disorders
that are induced by a high-fat diet and transmitted
through the epitranscriptomic markers m5C and m2G
on small non-coding RNAs in mice. Mofang Liu (CAS,
China) discussed the piwi/piRNA machinery in mamma-
lian spermiogenesis and human male infertility, and re-
vealed a novel mechanism for regulated packaging of
genomic DNA into functional sperm. Ramesh Pillai
(University of Geneva, Switzerland) introduced a critical
role of the m6A reader YTHDC2 in facilitating the
meiotic gene expression program during mouse sperm-
atogenesis. In oocytes, as shown by Donal O’Carroll
(MRC Center for Regenerative Medicine, UK), TUT4
and TUT7 catalyze uridylation and are required to
sculpt certain transcripts for the maternal transcriptome,
whereas the m6A reader YTHDF2 regulates transcript
dosage during oocyte maturation and is a key determin-
ant of egg quality.
Eric Phizicky (University of Rochester, USA) and col-
leagues characterized the highly conserved 2’-O-methyl-
transferase Trm7 in yeast. Trm7 mutants grow slowly
and have translation defects in Saccharomyces cerevisiae
and Schizosaccharomyces pombe, and they are associated
with intellectual disability in humans.
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work demonstrating the control of circadian rhythm by
m6A modification. The mRNAs of several clock genes
have high m6A levels, often in their 3’-UTRs, and inhib-
ition of m6A stabilizes these transcripts and prolongs the
circadian period.Interplay between RNA modifications and other
RNA regulatory processes
A recurring message at the conference was the inter-
play between multiple types of RNA modifications
and other RNA regulatory processes. For example, an
important molecular consequence of RNA modifica-
tions is differential affinity for RNA-binding proteins.
Yungui Yang (Beijing Institute of Genomics, China)
and colleagues identified YTHDC1, an m6A nuclear
reader that specifically recognizes m6A-modified tran-
scripts and regulates exon splicing by promoting or
antagonizing splicing factor binding. In a re-analysis
of previously published m6A-LAIC-seq data and
related datasets, Li Yang (CAS-MPG Partner Institute
for Computational Biology, China) discovered a global
downregulation of A-to-I editing in m6A-positive
compared to m6A-negative RNA populations, suggest-
ing a negative correlation between m6A modification
and A-to-I editing.
RNA modifications also mediate mRNA translational
control. Richard Gregory (Boston Children’s Hospital
and Harvard University, USA) described a looping
mechanism between stop-codon-associated m6A writer
METTL3 and the eIF complex that regulates protein
expression. This looping mechanism ensures that ribo-
somes are more efficiently recycled in METTL3-bound
mRNA transcripts.RNA modifications in plant biology
One session of the conference was dedicated to RNA
modifications in plants. Xuemei Chen (UC Riverside,
USA) presented a role for the TREXII complex in
miRNA biogenesis, export, and loading onto AGO1 in
Arabidopsis. The Chen group also identified HESO1 in
catalyzing pre-miRNA uridylation. Uridylation of
trimmed pre-miRNAs promotes their degradation.
Rupert Fray (University of Nottingham, UK) presented
a study of the m6A methylation complex in plants. The
identified components include MTA (METTL3), MTB
(METTL14), FIP37 (WTAP), Vir (KIAA1429), and
Hakai, a novel m6A writer that may also be conserved in
mammals. Guifang Jia (Peking University, China) pre-
sented the identification of the first plant m6A eraser,
AtALKBH10B. AtALKBH10B regulates the floral transi-
tion and vegetative growth in Arabidopsis.Methods for epitranscriptome sequencing
Several speakers presented novel methods for epitran-
scriptome sequencing. Dan Dominissini (Tel Aviv Uni-
versity, Israel) presented work on Nm sequencing.
Leveraging the differential reactivity of 2’-O-methylated
(Nm) and 2’-hydroxylated nucleosides, Nm-seq identifies
Nm sites at base resolution and characterizes the unique
features of Nm modification. Chengqi Yi (Peking Uni-
versity, China) presented CeU-seq and m1A-MAP, se-
quencing methods for detecting pseudouridine and
N1-methyladenosine (m1A), respectively. Specifically,
m1A-MAP leverages m1A induced mis-incorporation to
achieve single-base resolution for m1A site identification,
revealing the enrichment of m1A at the 5’-cap and
5’-UTR.
Shengdong Ke (Rockefeller University, USA) presented
efforts in developing m6A-CLIP to enable comprehen-
sive, single-base-resolution mapping of m6A sites across
the transcriptome. Yang Yu (CAS, China) presented a
highly efficient and sensitive CLIP method called
GoldCLIP that omits all gel purification steps to
characterize transcriptome-wide protein-RNA interactions.
Conclusions
Our understanding of the landscape, regulation, and
functions of RNA modifications has advanced tremen-
dously in the past few years. This CSHA conference
brought together a multidisciplinary group of re-
searchers studying RNA modifications in diverse
biological systems using a broad range of approaches.
With many questions still to be answered, we are excited
about future scientific explorations at the new frontiers
of RNA modifications and epitranscriptomics.
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